Authors: DUNCIA JV SANTELLA JB HIGLEY CA PITTS WJ WITYAK J FRIETZE WE RANKIN FW SUN JH EARL RA TABAKA AC TELEHA CA BLOM KF FAVATA MF MANOS EJ DAULERIO AJ STRADLEY DA HORIUCHI K COPELAND RA SCHERLE PA TRZASKOS JM MAGOLDA RL TRAINOR GL WEXLER RR HOBBS FW OLSON RE

Citation: Jv. Duncia et al., MEK INHIBITORS - THE CHEMISTRY AND BIOLOGICAL-ACTIVITY OF U0126, ITS ANALOGS, AND CYCLIZATION PRODUCTS, Bioorganic & medicinal chemistry letters, 8(20), 1998, pp. 2839-2844

Authors: HO SP BRITTON DHO STONE BA BEHRENS DL LEFFET LM HOBBS FW MILLER JA TRAINOR GL

Citation: Sp. Ho et al., POTENT ANTISENSE OLIGONUCLEOTIDES TO THE HUMAN MULTIDRUG RESISTANCE-1MESSENGER-RNA ARE RATIONALLY SELECTED BY MAPPING RNA-ACCESSIBLE SITESWITH OLIGONUCLEOTIDE LIBRARIES, Nucleic acids research, 24(10), 1996, pp. 1901-1907

Authors: SANDS H GOREYFERET L HO SP BAO Y COCUZZA AJ CHIDESTER D TRAINOR GL HOBBS FW

Citation: H. Sands et al., BIODISTRIBUTION AND METABOLISM OF H-3 INTERNAL LABELED OLIGONUCLEOTIDES - COMPARISON OF A PHOSPHOTHIOATE TO BOTH 3'5' BLOCKED AND UNBLOCKEDPHOSPHODIESTERS, Journal of cellular biochemistry, 1995, pp. 167-167

Authors: SANDS H GOREYFERET LJ HO SP BAO YJ COCUZZA AJ CHIDESTER D HOBBS FW

Citation: H. Sands et al., BIODISTRIBUTION AND METABOLISM OF INTERNALLY H-3 LABELED OLIGONUCLEOTIDES .2. 3',5'-BLOCKED OLIGONUCLEOTIDES, Molecular pharmacology, 47(3), 1995, pp. 636-646

Authors: SANDS H GOREYFERET LJ COCUZZA AJ HOBBS FW CHIDESTER D TRAINOR GL

Citation: H. Sands et al., BIODISTRIBUTION AND METABOLISM OF INTERNALLY H-3 LABELED OLIGONUCLEOTIDES .1. COMPARISON OF A PHOSPHODIESTER AND A PHOSPHOROTHIOATE, Molecular pharmacology, 45(5), 1994, pp. 932-943

Authors: HOBBS SH HOBBS FW

Citation: Sh. Hobbs et Fw. Hobbs, THE ETHICAL MANAGEMENT OF ASSETS FOR ELDER CLIENTS - A CONTEXT, ROLE,AND LAW APPROACH, Fordham law review, 62(5), 1994, pp. 1411-1428